193 related articles for article (PubMed ID: 30538125)
1. Prostate Cancer Risk-Associated Single-Nucleotide Polymorphism Affects Prostate-Specific Antigen Glycosylation and Its Function.
Srinivasan S; Stephens C; Wilson E; Panchadsaram J; DeVoss K; Koistinen H; Stenman UH; Brook MN; Buckle AM; Klein RJ; Lilja H; Clements J; Batra J;
Clin Chem; 2019 Jan; 65(1):e1-e9. PubMed ID: 30538125
[TBL] [Abstract][Full Text] [Related]
2. Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.
Cramer SD; Chang BL; Rao A; Hawkins GA; Zheng SL; Wade WN; Cooke RT; Thomas LN; Bleecker ER; Catalona WJ; Sterling DA; Meyers DA; Ohar J; Xu J
J Natl Cancer Inst; 2003 Jul; 95(14):1044-53. PubMed ID: 12865450
[TBL] [Abstract][Full Text] [Related]
3. Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels.
Penney KL; Schumacher FR; Kraft P; Mucci LA; Sesso HD; Ma J; Niu Y; Cheong JK; Hunter DJ; Stampfer MJ; Hsu SI
Carcinogenesis; 2011 Jun; 32(6):853-9. PubMed ID: 21421545
[TBL] [Abstract][Full Text] [Related]
4. Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Huber A; Lümmen G; Tscholl R
Urology; 2000 Apr; 55(4):481-5. PubMed ID: 10736487
[TBL] [Abstract][Full Text] [Related]
5. KLK3 SNP-SNP interactions for prediction of prostate cancer aggressiveness.
Lin HY; Huang PY; Cheng CH; Tung HY; Fang Z; Berglund AE; Chen A; French-Kwawu J; Harris D; Pow-Sang J; Yamoah K; Cleveland JL; Awasthi S; Rounbehler RJ; Gerke T; Dhillon J; Eeles R; Kote-Jarai Z; Muir K; ; Schleutker J; Pashayan N; ; Neal DE; Nielsen SF; Nordestgaard BG; Gronberg H; Wiklund F; Giles GG; Haiman CA; Travis RC; Stanford JL; Kibel AS; Cybulski C; Khaw KT; Maier C; Thibodeau SN; Teixeira MR; Cannon-Albright L; Brenner H; Kaneva R; Pandha H; ; Srinivasan S; Clements J; Batra J; Park JY
Sci Rep; 2021 Apr; 11(1):9264. PubMed ID: 33927218
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the Glycosylation Site of Human PSA Prompted by Missense Mutation using LC-MS/MS.
Song E; Hu Y; Hussein A; Yu CY; Tang H; Mechref Y
J Proteome Res; 2015 Jul; 14(7):2872-83. PubMed ID: 26022737
[TBL] [Abstract][Full Text] [Related]
7. Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 microg/L: are they useful tools for early detection and screening of prostate cancer?
Jung K; Stephan C; Elgeti U; Lein M; Brux B; Kristiansen G; Rudolph B; Hauptmann S; Schnorr D; Loening SA; Sinha P
Int J Cancer; 2001 Sep; 93(5):759-65. PubMed ID: 11477592
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.
Kim S; Shin C; Jee SH
Gene; 2015 Feb; 556(2):199-205. PubMed ID: 25434496
[TBL] [Abstract][Full Text] [Related]
9. Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.
Haese A; Graefen M; Steuber T; Becker C; Pettersson K; Piironen T; Noldus J; Huland H; Lilja H
Prostate; 2001 Oct; 49(2):101-9. PubMed ID: 11582588
[TBL] [Abstract][Full Text] [Related]
10. Total and transition zone prostate volume and age: how do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection?
Djavan B; Zlotta AR; Remzi M; Ghawidel K; Bursa B; Hruby S; Wolfram R; Schulman CC; Marberger M
Urology; 1999 Nov; 54(5):846-52. PubMed ID: 10565745
[TBL] [Abstract][Full Text] [Related]
11. A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.
Nordström T; Aly M; Eklund M; Egevad L; Grönberg H
Eur Urol; 2014 Jun; 65(6):1184-90. PubMed ID: 23891454
[TBL] [Abstract][Full Text] [Related]
12. Ratio of alpha 1-antichymotrypsin--prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis.
Lein M; Jung K; Elgeti U; Brux B; Sinha P; Schnorr D; Loening SA
Anticancer Res; 2000; 20(6D):4997-5001. PubMed ID: 11326657
[TBL] [Abstract][Full Text] [Related]
13. Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: which is clinically effective and when?
Basso D; Fogar P; Piva MG; Navaglia F; Mazza S; Prayer-Galetti T; Castellucci E; Pagano F; Plebani M
Urology; 2000 May; 55(5):710-5. PubMed ID: 10792086
[TBL] [Abstract][Full Text] [Related]
14. Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels.
Parikh H; Wang Z; Pettigrew KA; Jia J; Daugherty S; Yeager M; Jacobs KB; Hutchinson A; Burdett L; Cullen M; Qi L; Boland J; Collins I; Albert TJ; Vatten LJ; Hveem K; Njølstad I; Cancel-Tassin G; Cussenot O; Valeri A; Virtamo J; Thun MJ; Feigelson HS; Diver WR; Chatterjee N; Thomas G; Albanes D; Chanock SJ; Hunter DJ; Hoover R; Hayes RB; Berndt SI; Sampson J; Amundadottir L
Hum Genet; 2011 Jun; 129(6):675-85. PubMed ID: 21318478
[TBL] [Abstract][Full Text] [Related]
15. Alpha 1 antichymotrypsin genotype is associated with increased risk of prostate carcinoma and PSA levels.
Licastro F; Bertaccini A; Porcellini E; Chiappelli M; Pernetti R; Sanguedolce F; Marchiori D; Martorana G
Anticancer Res; 2008; 28(1B):395-9. PubMed ID: 18383875
[TBL] [Abstract][Full Text] [Related]
16. PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility.
Lai J; Kedda MA; Hinze K; Smith RL; Yaxley J; Spurdle AB; Morris CP; Harris J; Clements JA
Carcinogenesis; 2007 May; 28(5):1032-9. PubMed ID: 17151093
[TBL] [Abstract][Full Text] [Related]
17. Association between RNASEL, MSR1, and ELAC2 single nucleotide polymorphisms and gene expression in prostate cancer risk.
Alvarez-Cubero MJ; Pascual-Geler M; Martinez-Gonzalez LJ; Expósito Ruiz M; Saiz M; Cozar JM; Lorente JA
Urol Oncol; 2016 Oct; 34(10):431.e1-8. PubMed ID: 27318894
[TBL] [Abstract][Full Text] [Related]
18. Association between three genetic variants in kallikrein 3 and prostate cancer risk.
Ding WH; Ren KW; Yue C; Zou JG; Zuo L; Zhang LF; Bai Y; Okada A; Yasui T; Mi YY
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413614
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis.
Lein M; Jung K; Elgeti U; Petras T; Stephan C; Brux B; Sinha P; Winkelmann B; Schnorr D; Loening S
Eur Urol; 2001 Jan; 39(1):57-64. PubMed ID: 11173940
[TBL] [Abstract][Full Text] [Related]
20. Single-nucleotide polymorphism rs1058205 of KLK3 is associated with the risk of prostate cancer: A case-control study of Han Chinese men in Northeast China.
Chen C; Xin Z
Medicine (Baltimore); 2017 Mar; 96(10):e6280. PubMed ID: 28272245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
